266
Views
33
CrossRef citations to date
0
Altmetric
Original Article: Research

Role of Yin Yang-1 (YY1) in the transcription regulation of the multi-drug resistance (MDR1) gene

, , , , , , , , , & show all
Pages 2628-2638 | Received 17 Oct 2017, Accepted 17 Feb 2018, Published online: 04 Apr 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Gabriela Antonio-Andres, Elva Jiménez-Hernandez, Laura A. Estrada-Abreo, Yanelly Garfias-Gómez, Genaro Patino-Lopez, Sergio Juarez-Mendez & Sara Huerta-Yepez. (2021) Expression of YY1 in pro-B and T phenotypes correlation with poor survival in pediatric acute lymphoblastic leukemia. Pediatric Hematology and Oncology 38:5, pages 456-470.
Read now

Articles from other publishers (32)

Yan Zhao, Cheng Xing, Yating Deng, Can Ye & Hongling Peng. (2024) HIF-1α signaling: Essential roles in tumorigenesis and implications in targeted therapies. Genes & Diseases 11:1, pages 234-251.
Crossref
Pradhapsingh Bharathiraja, Priya Yadav, Andaleeb Sajid, Suresh V. Ambudkar & N. Rajendra Prasad. (2023) Natural medicinal compounds target signal transduction pathways to overcome ABC drug efflux transporter-mediated multidrug resistance in cancer. Drug Resistance Updates 71, pages 101004.
Crossref
Bowen Wu, Peng Li, Eryue Qiu & Jian Chen. (2023) Metformin alleviates adriamycin resistance of osteosarcoma by declining YY1 to inhibit MDR1 transcriptional activity. BMC Pharmacology and Toxicology 24:1.
Crossref
Megan Jung, Indy Bui & Benjamin Bonavida. (2023) Role of YY1 in the Regulation of Anti-Apoptotic Gene Products in Drug-Resistant Cancer Cells. Cancers 15:17, pages 4267.
Crossref
Rendy Hosea, Sharon Hillary, Shourong Wu & Vivi Kasim. (2023) Targeting Transcription Factor YY1 for Cancer Treatment: Current Strategies and Future Directions. Cancers 15:13, pages 3506.
Crossref
Donghu Yu, Chen Chen, Le Sun, Shaojie Wu, Xiaoyu Tang, Liye Mei, Cheng Lei, Du Wang, Xinghuan Wang, Liang Cheng & Sheng Li. (2023) KRT13-expressing epithelial cell population predicts better response to chemotherapy and immunotherapy in bladder cancer: Comprehensive evidences based on BCa database. Computers in Biology and Medicine 158, pages 106795.
Crossref
Xinghao Fu, Feihong Ji, Qi He & Xinguang Qiu. (2022) A Systematic Pan-Cancer Analysis of YY1 Aberrations and their Relationship with Clinical Outcome, Tumor Microenvironment, and Therapeutic Targets. Journal of Immunology Research 2022, pages 1-23.
Crossref
Alicja Warowicka, Justyna Broniarczyk, Martyna Węglewska, Wojciech Kwaśniewski & Anna Goździcka-Józefiak. (2022) Dual Role of YY1 in HPV Life Cycle and Cervical Cancer Development. International Journal of Molecular Sciences 23:7, pages 3453.
Crossref
Yin Shen, Quan Zhong, Tian Liu, Zi Wen, Wei Shen & Li Li. (2022) CharID: a two-step model for universal prediction of interactions between chromatin accessible regions. Briefings in Bioinformatics 23:2.
Crossref
Nami Sato, Nozomu Sakai, Katsunori Furukawa, Tsukasa Takayashiki, Satoshi Kuboki, Shigetsugu Takano, Gaku Ohira, Hisahiro Matsubara & Masayuki Ohtsuka. (2022) Yin Yang 1 regulates ITGAV and ITGB1, contributing to improved prognosis of colorectal cancer. Oncology Reports 47:5.
Crossref
Gabriela Antonio-Andres, Gustavo U. Martinez-Ruiz, Mario Morales-Martinez, Elva Jiménez-Hernandez, Estefany Martinez-Torres, Tania V. Lopez-Perez, Laura A. Estrada-Abreo, Genaro Patino-Lopez, Sergio Juarez-Mendez, Víctor M. Davila-Borja & Sara Huerta-Yepez. (2022) Transcriptional Regulation of Yin-Yang 1 Expression through the Hypoxia Inducible Factor-1 in Pediatric Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences 23:3, pages 1728.
Crossref
T. A. Bairova, N. V. Nemchinova, E. V. Belyaeva, A. Yu. Sambyalova, O. A. Ershova & L. V. Rychkova. (2022) The Prevalence of Polymorphic Variants of ABCB1 Gene among Indigenous Populations of Siberia. Russian Journal of Genetics 58:1, pages 57-64.
Crossref
庆艳 曹. (2022) Research Progress of YY1 Protein in Hematologic Malignancies. Advances in Clinical Medicine 12:04, pages 3047-3052.
Crossref
Gustavo Ulises Martinez-Ruiz, Abigail Morales-Sanchez & Angel Francisco Pacheco-Hernandez. (2021) Roles Played by YY1 in Embryonic, Adult and Cancer Stem Cells. Stem Cell Reviews and Reports 17:5, pages 1590-1606.
Crossref
Ponmathi Panneerpandian, Divya Bhaskar Rao & Kumaresan Ganesan. (2021) Calcium channel blockers lercanidipine and amlodipine inhibit YY1/ERK/TGF-β mediated transcription and sensitize the gastric cancer cells to doxorubicin. Toxicology in Vitro 74, pages 105152.
Crossref
Fu-Ying Dao, Hao Lv, Dan Zhang, Zi-Mei Zhang, Li Liu & Hao Lin. (2021) DeepYY1: a deep learning approach to identify YY1-mediated chromatin loops. Briefings in Bioinformatics 22:4.
Crossref
Divya Bhaskar Rao, Ponmathi Panneerpandian, Karthik Balakrishnan & Kumaresan Ganesan. (2021) YY1 regulated transcription‐based stratification of gastric tumors and identification of potential therapeutic candidates. Journal of Cell Communication and Signaling 15:2, pages 251-267.
Crossref
Siyi Li, Zhi Zhang, Hongjuan Peng & Xiongsheng Xiao. (2021) YY1-induced up-regulation of FOXE1 is negatively regulated by miR-129-5p and contributes to the progression of papillary thyroid microcarcinoma. Pathology - Research and Practice 221, pages 153337.
Crossref
Annalisa Tameni, Elisabetta Sauta, Valentina Mularoni, Federica Torricelli, Gloria Manzotti, Giorgio Inghirami, Riccardo Bellazzi, Valentina Fragliasso & Alessia Ciarrocchi. (2021) The DNA-helicase HELLS drives ALK− ALCL proliferation by the transcriptional control of a cytokinesis-related program. Cell Death & Disease 12:1.
Crossref
Narges Aberuyi, Soheila Rahgozar, Elnaz Pourabutaleb & Kamran Ghaedi. (2021) Selective dysregulation of ABC transporters in methotrexate-resistant leukemia T-cells can confer cross-resistance to cytarabine, vincristine and dexamethasone, but not doxorubicin. Current Research in Translational Medicine 69:1, pages 103269.
Crossref
Tania V. Lopez-Perez, Belen Tirado-Rodriguez, Mario Morales-Martinez, Mayra Montecillo-Aguado & Sara Huerta-Yepez. 2021. YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer. YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer 251 268 .
Gabriele Michele, Testa Giuseppe & Hansen Anders. 2021. YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer. YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer 123 147 .
Mario Morales-Martinez & Mario I. Vega. 2021. YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer. YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer 171 198 .
Xianping Huang, Weihe Zhou & Yuefeng Zhang. (2020) Transcription factor YY1 enhances the stemness of lung cancer cells by stabilizing hypoxia factor HIF ‐1α under a hypoxic microenvironment . Environmental Toxicology 36:1, pages 114-122.
Crossref
Mario Morales-Martinez, Gabriel G. Vega, Natividad Neri, M. J Nambo, Isabel Alvarado, Ivonne Cuadra, M. A. Duran-Padilla, Sara Huerta-Yepez & Mario I. Vega. (2020) MicroRNA-7 Regulates Migration and Chemoresistance in Non-Hodgkin Lymphoma Cells Through Regulation of KLF4 and YY1. Frontiers in Oncology 10.
Crossref
Silvia Vivarelli, Luca Falzone, Giovanni Ligresti, Saverio Candido, Adriana Garozzo, Gaetano Giuseppe Magro, Benjamin Bonavida & Massimo Libra. (2020) Role of the Transcription Factor Yin Yang 1 and Its Selectively Identified Target Survivin in High-Grade B-Cells Non-Hodgkin Lymphomas: Potential Diagnostic and Therapeutic Targets. International Journal of Molecular Sciences 21:17, pages 6446.
Crossref
Qiuli Li, Weichao Chen, Rongzhen Luo, Zhiyi Zhang, Ming Song, Wenkuan Chen, Zhongyuan Yang, Yuanzhong Yang, Zhuming Guo & Ankui Yang. (2020) RETRACTED: Upregulation of OIP5-AS1 Predicts Poor Prognosis and Contributes to Thyroid Cancer Cell Proliferation and Migration. Molecular Therapy - Nucleic Acids 20, pages 279-291.
Crossref
Narges Aberuyi, Soheila Rahgozar, Elaheh Sadat Ghodousi & Kamran Ghaedi. (2020) Drug Resistance Biomarkers and Their Clinical Applications in Childhood Acute Lymphoblastic Leukemia. Frontiers in Oncology 9.
Crossref
Sailu Sarvagalla, Srinivasa Prasad Kolapalli & Sivakumar Vallabhapurapu. (2019) The Two Sides of YY1 in Cancer: A Friend and a Foe. Frontiers in Oncology 9.
Crossref
Marta Zapata-Tarres, Luis E Juarez-Villegas, Altagracia Maldonado-Valenzuela, Guillermina J Baay-Guzman, Tania V Lopez-Perez, Lourdes Cabrera-Muñoz, Stanislaw Sadowinski-Pine & Sara Huerta-Yepez. (2019) Expression of YY1 in Wilms tumors with favorable histology is a risk factor for adverse outcomes. Future Oncology 15:11, pages 1231-1241.
Crossref
Mario Morales-Martinez, Alberto Valencia-Hipolito, Gabriel G. Vega, Natividad Neri, Maria J. Nambo, Isabel Alvarado, Ivonne Cuadra, Marco A. Duran-Padilla, Otoniel Martinez-Maza, Sara Huerta-Yepez & Mario I. Vega. (2019) Regulation of Krüppel-Like Factor 4 (KLF4) expression through the transcription factor Yin-Yang 1 (YY1) in non-Hodgkin B-cell lymphoma. Oncotarget 10:22, pages 2173-2188.
Crossref
Lu Zhao, Ran Li & Ye-Hua Gan. (2018) Knockdown of Yin Yang 1 enhances anticancer effects of cisplatin through protein phosphatase 2A-mediated T308 dephosphorylation of AKT. Cell Death & Disease 9:7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.